Janux is a clinical-stage company developing precision-engineered immunotherapies that have the potential to generate potent and durable immune responses without causing systemic safety issues
Janux is a clinical-stage company developing precision-engineered immunotherapies that have the potential to generate potent and durable immune responses without causing systemic safety issues. The company is focused on addressing critical unmet needs in the treatment of cancer and autoimmune diseases.